BiotechTube
Home/Pipeline/Sanoosa‑003

Sanoosa‑003

COVID‑19 Antiviral

PreclinicalActive

Key Facts

Indication
COVID‑19 Antiviral
Phase
Preclinical
Status
Active
Company
Sanoosa

About Sanoosa

Australian biotech developing oral small‑molecule drugs for inflammation, oncology and viral infections.

View full company profile

Therapeutic Areas

ImmunologyOncologyInfectious Diseases